Department of Radiology, Translational Research in Ultrasound Theranostics (TRUST) Program, University of Texas Southwestern Medical Center, Dallas, Texas 75390, United States.
Biomedical Engineering Graduate Program, University of Texas Southwestern Medical Center, Dallas, Texas 75390, United States.
ACS Appl Mater Interfaces. 2023 Sep 13;15(36):42413-42423. doi: 10.1021/acsami.3c11976. Epub 2023 Aug 31.
Activating patients' immune cells, either by reengineering them or treating them with bioactive molecules, has been a breakthrough in the field of immunotherapy and has revolutionized treatment, especially against cancer. As immune cells naturally home to tumors or injured tissues, labeling such cells holds promise for non-invasive tracking and biologic manipulation. Our study demonstrates that macrophages loaded with extremely low boiling point perfluorocarbon nanodroplets not only survive ultrasound-induced phase change but also maintain their phagocytic function. Unlike observations made when using higher boiling point perfluorocarbon nanodroplets, our results show that phase change occurs intracellularly at a low mechanical index using a clinical scanner operating within the energy limit set by the Food and Drug Administration (FDA). After nanodroplet-loaded macrophages were given intravenously to nude rats, they were invisible in the liver when imaged at a very low mechanical index using a clinical ultrasound scanner. They became visible when power was increased but still within the FDA limits up to 8 h after administration. The acoustic labeling and in vivo detection of macrophages using a clinical ultrasound scanner represent a paradigm shift in the field of cell tracking and pave the way for potential therapeutic strategies in the clinical setting.
激活患者的免疫细胞,无论是通过对其进行工程改造还是用生物活性分子进行治疗,这在免疫疗法领域已经是一项突破,它革新了治疗方法,尤其是在癌症治疗方面。由于免疫细胞会自然地归巢到肿瘤或受损组织中,因此对这些细胞进行标记有望实现非侵入性的跟踪和生物学操作。我们的研究表明,负载极低沸点全氟碳纳米液滴的巨噬细胞不仅能在超声诱导的相变中存活,而且还能保持其吞噬功能。与使用较高沸点的全氟碳纳米液滴时的观察结果不同,我们的结果表明,在使用临床扫描仪以低于食品和药物管理局 (FDA) 设定的能量限制的机械指数进行操作时,相变会在细胞内发生。将负载纳米液滴的巨噬细胞静脉注射到裸鼠体内后,当使用临床超声扫描仪以非常低的机械指数进行成像时,它们在肝脏中不可见。当功率增加但仍在 FDA 限制范围内时,它们在给药后 8 小时内变得可见。使用临床超声扫描仪对巨噬细胞进行声标记和体内检测代表了细胞跟踪领域的范式转变,并为临床环境中的潜在治疗策略铺平了道路。